BioAge Labs, Inc.
BIOA
$4.38
$0.153.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,537.17% | -- | -- | 529.40% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 689.11% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 1,311.14% | -- | -- | -- | |
|
|
|||||
| Total Current Assets | 1,311.14% | -- | -- | -- | |
| Net Property, Plant & Equipment | 52.70% | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 1,281.86% | -- | -- | -- | |
|
|
|||||
| Total Accounts Payable | 6.97% | -- | -- | -- | |
| Total Accrued Expenses | 73.06% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 0.13% | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 75.31% | -- | -- | -- | |
| Total Other Current Liabilities | 75.31% | -- | -- | -- | |
| Total Current Liabilities | -52.25% | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | -52.25% | -- | -- | -- | |
| Long-Term Debt | -69.49% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 2,009.17% | -- | -- | -- | |
| Total Liabilities | -47.29% | -- | -- | -- | |
|
|
|||||
| Common Stock & APIC | 6,970.66% | -- | -- | -- | |
| Retained Earnings | -39.13% | -- | -- | -- | |
| Treasury Stock & Other | 49.39% | -- | -- | -- | |
| Total Common Equity | 286.35% | -- | -- | -64.81% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 158.31% | |
|
|
|||||
| Total Common Equity | 286.35% | -- | -- | -64.81% | |
| Total Preferred Equity | -- | -- | -- | 158.31% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 894.43% | -- | -- | 680.24% | |
|
|
|||||